Publication Date
| In 2024 | 0 |
| Since 2023 | 0 |
| Since 2020 (last 5 years) | 0 |
| Since 2015 (last 10 years) | 0 |
| Since 2005 (last 20 years) | 1 |
Descriptor
| Behavior Change | 1 |
| Behavior Disorders | 1 |
| Drug Therapy | 1 |
| Eating Disorders | 1 |
| Genetic Disorders | 1 |
| Human Body | 1 |
| Language Skills | 1 |
| Outcomes of Treatment | 1 |
| Patients | 1 |
| Surveys | 1 |
| Symptoms (Individual… | 1 |
| More ▼ | |
Source
| American Journal on… | 1 |
Author
| Chonchaiya, Weerasak | 1 |
| Ethell, Iryna M. | 1 |
| Faradz, Sultana M. H. | 1 |
| Hagerman, Randi J. | 1 |
| Nguyen, Danh V. | 1 |
| Rivera, Susan M. | 1 |
| Schneider, Andrea | 1 |
| Utari, Agustini | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkUtari, Agustini; Chonchaiya, Weerasak; Rivera, Susan M.; Schneider, Andrea; Hagerman, Randi J.; Faradz, Sultana M. H.; Ethell, Iryna M.; Nguyen, Danh V. – American Journal on Intellectual and Developmental Disabilities, 2010
Minocycline can rescue the dendritic spine and synaptic structural abnormalities in the fragile X knock-out mouse. This is a review and preliminary survey to document side effects and potential outcome measures for minocycline use in the treatment of individuals with fragile X syndrome. We surveyed 50 patients with fragile X syndrome who received…
Descriptors: Behavior Disorders, Patients, Drug Therapy, Genetic Disorders
